Clin2
NCT02037867Possibly a fitRecruiting

Study your liver blood markers if you’re at risk

Chronic Liver DiseaseAlcohol Use DisorderType 2 DiabetesPersistently Elevated ALTObesity

Part of Digestive system, Hormones & metabolism, Mental health clinical trials.

This study looks at how certain blood tests (liver biomarkers) change in people with higher risk for liver disease. It may help doctors understand who is developing liver problems earlier and what patterns in blood tests matter most.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
2,000 people
Ages
18 years and older
Study type
Observational

Who can take part

  • Be 18 years old or older
  • Have at least one main risk factor for liver disease: heavy alcohol use, type 2 diabetes, obesity, or consistently high ALT with normal other liver blood tests
  • You must be able to understand the study and give informed consent
  • You should not have active cancer at the time you enroll
  • You should not already have a confirmed liver disease diagnosis from a liver biopsy (histology) before starting this study pathway

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04371042Recruiting
Study of liver disease and genes in people with fatty liver

This study collects information about metabolic and unexplained (cryptogenic) liver disease and looks at “omics” tests, which are lab tests that measure patterns in blood or tissue to learn what drives the disease. It may help researchers better understand fatty liver and related serious complications, like liver scarring and liver cancer.

Roma, Rome/lazio/italy
NCT07658755Recruiting
LiverSeek: Finding advanced liver scarring in MASLD

This study uses routine blood tests to find people with advanced liver scarring caused by a condition called MASLD. If you are between 50 and 75, have certain metabolic risks, and get blood work from your primary care doctor at select centers, you may be eligible.

Madrid, Madrid
NCT05312853Not yet recruiting
Testing non-invasive checks to predict liver disease progression

This study looks at non-invasive tests (tests that don’t require surgery) to see whether they can diagnose and predict how chronic liver disease will worsen over time. If you may have chronic liver disease, these tests could help doctors follow your condition more accurately.

Mainz
NCT06396871Recruiting
Blood cell study in metabolic diseases

This study looks at blood cells and factors in people with metabolic diseases like fatty liver, prediabetes, or type 2 diabetes. It aims to better understand these conditions by comparing them with healthy volunteers.

Dresden, Saxony
NCT07191561Recruiting
Liver fat and alcohol use disorder study

This trial looks at how the liver processes fat in people with alcohol use disorder. It may help find better ways to treat liver problems related to drinking.

Bethesda, Maryland
NCT04666402Recruiting
Testing better ways to diagnose early liver disease

This study looks at integrated diagnostic tests to find early liver problems sooner. It may help you (if referred to the community liver clinic) get more timely information about what’s going on.

Manchester, Greater Manchester

Hear when a new Chronic Liver Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.